Dana N. Raugi

1.3k total citations
26 papers, 578 citations indexed

About

Dana N. Raugi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Dana N. Raugi has authored 26 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 23 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Dana N. Raugi's work include HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (19 papers). Dana N. Raugi is often cited by papers focused on HIV Research and Treatment (23 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (19 papers). Dana N. Raugi collaborates with scholars based in United States, Senegal and France. Dana N. Raugi's co-authors include Geoffrey S. Gottlieb, Robert A. Smith, James I. Mullins, Papa Salif Sow, Moussa Seydi, Selly Ba, Stephen E. Hawes, Wenjie Deng, Kim Wong and Vincent H. Wu and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

Dana N. Raugi

25 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana N. Raugi United States 15 415 395 131 109 59 26 578
Vlad Novitsky United States 12 337 0.8× 387 1.0× 150 1.1× 69 0.6× 91 1.5× 34 491
Michel P. de Baar Netherlands 12 325 0.8× 292 0.7× 105 0.8× 119 1.1× 39 0.7× 16 511
Susan Buchbinder United States 4 216 0.5× 214 0.5× 134 1.0× 110 1.0× 107 1.8× 6 468
Maofeng Qiu China 8 263 0.6× 183 0.5× 104 0.8× 56 0.5× 20 0.3× 16 334
Nicholas Bbosa Uganda 6 259 0.6× 278 0.7× 94 0.7× 74 0.7× 21 0.4× 19 356
Natalia Zahonero Spain 16 701 1.7× 724 1.8× 157 1.2× 132 1.2× 75 1.3× 22 818
Claudia García‐Morales Mexico 12 276 0.7× 263 0.7× 93 0.7× 35 0.3× 39 0.7× 31 347
Xiaoxu Han China 12 268 0.6× 187 0.5× 178 1.4× 61 0.6× 14 0.2× 22 396
Torange Yeghiazarian United States 7 327 0.8× 386 1.0× 130 1.0× 72 0.7× 50 0.8× 9 522
Filip Van Wanzeele Belgium 12 408 1.0× 359 0.9× 107 0.8× 39 0.4× 37 0.6× 20 623

Countries citing papers authored by Dana N. Raugi

Since Specialization
Citations

This map shows the geographic impact of Dana N. Raugi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana N. Raugi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana N. Raugi more than expected).

Fields of papers citing papers by Dana N. Raugi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana N. Raugi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana N. Raugi. The network helps show where Dana N. Raugi may publish in the future.

Co-authorship network of co-authors of Dana N. Raugi

This figure shows the co-authorship network connecting the top 25 collaborators of Dana N. Raugi. A scholar is included among the top collaborators of Dana N. Raugi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana N. Raugi. Dana N. Raugi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Robert A., et al.. (2023). Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232. PLoS ONE. 18(1). e0280568–e0280568. 2 indexed citations
2.
3.
Raugi, Dana N., et al.. (2020). HIV-2 Drug Resistance Genotyping from Dried Blood Spots. Journal of Clinical Microbiology. 59(1). 1 indexed citations
4.
Ba, Selly, Stephen E. Hawes, Fatima Sall, et al.. (2019). Infection à VIH-2 au Sénégal: échecs virologiques et résistances aux antirétroviraux (ARV). Pan African Medical Journal. 33. 222–222. 2 indexed citations
5.
Wang, Jiasi, Jason E. Kreutz, Yuling Qin, et al.. (2018). SD-chip enabled quantitative detection of HIV RNA using digital nucleic acid sequence-based amplification (dNASBA). Lab on a Chip. 18(22). 3501–3506. 42 indexed citations
6.
Smith, Robert A., Vincent H. Wu, Dana N. Raugi, et al.. (2018). In VitroAntiviral Activity of Cabotegravir against HIV-2. Antimicrobial Agents and Chemotherapy. 62(10). 17 indexed citations
7.
Chang, Ming, Dana N. Raugi, Robert A. Smith, et al.. (2017). Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test. Journal of Clinical Virology. 97. 22–25. 12 indexed citations
8.
9.
Smith, Robert A., Dana N. Raugi, Papa Salif Sow, et al.. (2015). In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2. Retrovirology. 12(1). 10–10. 31 indexed citations
10.
Raugi, Dana N., Robert A. Smith, & Geoffrey S. Gottlieb. (2015). Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors. Journal of Virology. 90(2). 1062–1069. 23 indexed citations
11.
Smith, Robert A., Dana N. Raugi, Vincent H. Wu, et al.. (2015). The Nucleoside Analog BMS-986001 Shows GreaterIn VitroActivity against HIV-2 than against HIV-1. Antimicrobial Agents and Chemotherapy. 59(12). 7437–7446. 15 indexed citations
12.
Schuler, Bryce, Luyuan Li, Michal Mokrý, et al.. (2014). Major and Minor Group Rhinoviruses Elicit Differential Signaling and Cytokine Responses as a Function of Receptor-Mediated Signal Transduction. PLoS ONE. 9(4). e93897–e93897. 29 indexed citations
13.
Raugi, Dana N., Geoffrey S. Gottlieb, Papa Salif Sow, et al.. (2013). HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4+ cell counts. AIDS. 27(15). 2441–2450. 11 indexed citations
14.
15.
Smith, Robert A., Dana N. Raugi, Nancy B. Kiviat, et al.. (2011). Phenotypic susceptibility of HIV-2 to raltegravir. AIDS. 25(18). 2235–2241. 22 indexed citations
16.
Herbeck, Joshua T., Morgane Rolland, Yi Liu, et al.. (2011). Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes. Journal of Virology. 85(15). 7523–7534. 70 indexed citations
17.
Campbell, Mary S., James I. Mullins, James P. Hughes, et al.. (2011). Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial. PLoS ONE. 6(3). e16986–e16986. 66 indexed citations
18.
Gottlieb, Geoffrey S., Robert A. Smith, Ndèye Méry Dia Badiane, et al.. (2011). HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa. PLoS ONE. 6(7). e22204–e22204. 20 indexed citations
19.
Rolland, Morgane, Jonathan M. Carlson, Wenjie Deng, et al.. (2010). Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics. PLoS ONE. 5(9). e12463–e12463. 41 indexed citations
20.
Gottlieb, Geoffrey S., Stephen E. Hawes, Kim Wong, et al.. (2008). HIV Type 2 Protease, Reverse Transcriptase, and Envelope Viral Variation in the PBMC and Genital Tract of ARV-Naive Women in Senegal. AIDS Research and Human Retroviruses. 24(6). 857–864. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vlad Novitsky Breakdown of academic impact, for papers by Michel P. de Baar Breakdown of academic impact, for papers by Susan Buchbinder Breakdown of academic impact, for papers by Maofeng Qiu Breakdown of academic impact, for papers by Nicholas Bbosa Breakdown of academic impact, for papers by Natalia Zahonero Breakdown of academic impact, for papers by Claudia García‐Morales Breakdown of academic impact, for papers by Xiaoxu Han Breakdown of academic impact, for papers by Torange Yeghiazarian Breakdown of academic impact, for papers by Filip Van Wanzeele
Rankless by CCL
2026